BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-04-14
• Last 15 days FTD volume: HK$3.23 M
• Last 3 months FTD volume: HK$4.83 M
• Last 12 months FTD volume: HK$9.33 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	HK$33.09 M	HK$0.12 B	🇺🇸 USA
GSK plc GSK	HK$43.59 M	HK$0.24 B	🇬🇧 UK
Sarepta Therapeutics SRPT	HK$4.41 M	HK$20.61 M	🇺🇸 USA
Repligen RGEN	HK$8.24 M	HK$19.95 M	🇺🇸 USA
Novavax NVAX	HK$9.43 M	HK$62.18 M	🇺🇸 USA
Celldex Therapeutics CLDX	HK$1.97 M	HK$11.27 M	🇺🇸 USA
NanoViricides NNVC	HK$0.05 M	HK$4.07 M	🇺🇸 USA
Cel-Sci CVM	N/A	HK$0.07 M	🇺🇸 USA
Emergent BioSolutions EBS	HK$0.26 M	HK$3.65 M	🇺🇸 USA